Pyrazinamide contraindications: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Pyrazinamide }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PYRAZINAMIDE (PYRAZINAMIDE) TABLET [MIK..." |
No edit summary |
||
| Line 5: | Line 5: | ||
==CONTRAINDICATIONS== | |||
Pyrazinamide is contraindicated in persons:<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PYRAZINAMIDE (PYRAZINAMIDE) TABLET [MIKART, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a719ec72-771f-49c9-b93d-9d5f585176a4 | publisher = | date = | accessdate = }}</ref> | |||
*with severe hepatic damage. | |||
*who have shown hypersensitivity to it. | |||
*with acute gout | |||
==References== | ==References== | ||
Revision as of 01:29, 4 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
CONTRAINDICATIONS
Pyrazinamide is contraindicated in persons:[1]
- with severe hepatic damage.
- who have shown hypersensitivity to it.
*with acute gout
References
Adapted from the FDA Package Insert.